Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United State…
$1.09+3.81%
报价 2026-11-06
市值
$109.2M
EV
$90.6M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -61.8%
$0.84$2.85
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| STXSStereotaxis, Inc. | $109.2M | +3.8% | +20.1% | 55.6% | – | – | – | |
| NEONeoGenomics, Inc. | $2.19B | +2.1% | +10.3% | 42.9% | – | 54.0x | – | |
| SGMTSagimet Biosciences Inc. | $320.9M | +8.0% | -90.0% | 0% | – | – | – | |
| ARCTArcturus Therapeutics Holdings Inc. | $294.2M | +10.6% | -81.3% | 24% | – | – | – | |
| SMTISanara MedTech Inc. | $289.9M | -0.2% | +14.4% | 91.3% | – | 37.4x | 71.2x | |
| OSUROraSure Technologies, Inc. | $237.3M | +2.1% | +4.4% | 41% | – | – | – | |
| XGNExagen Inc. | $140.7M | -23.6% | +7.7% | 58.6% | – | – | – | |
| QTRXQuanterix Corporation | $136.9M | +4.9% | +27.6% | 42.6% | – | – | – | |
| HUMAHumacyte, Inc. | $124.5M | +13.3% | +174.1% | -666.8% | – | – | – | |
| 同行中位数 | – | – | +9.0% | 41.8% | – | 45.7x | 71.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。